Frontier Capital Management’s Keros Therapeutics KROS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-287,484	Closed	-$16.7M	–	294
2024 Q3	$16.7M	Buy	+287,484	New	+$16.7M	0.16%	181